Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Net Change in Investments - Total 2011-2025 | ZTS

Zoetis annual/quarterly net change in investments - total history and growth rate from 2011 to 2025. Net change in investments - total can be defined as the total change in long term and short term investments
  • Zoetis net change in investments - total for the quarter ending June 30, 2025 was $-3M, a 0% increase year-over-year.
  • Zoetis net change in investments - total for the twelve months ending June 30, 2025 was $-15M, a 36.36% increase year-over-year.
  • Zoetis annual net change in investments - total for 2024 was $-0.005B, a 25% increase from 2023.
  • Zoetis annual net change in investments - total for 2023 was $-0.004B, a 55.56% decline from 2022.
  • Zoetis annual net change in investments - total for 2022 was $-0.009B, a 25% decline from 2021.
  
Zoetis Annual Net Change in Investments - Total
(Millions of US $)
2024 $-5
2023 $-4
2022 $-9
2021 $-12
2020 $N/A
2019 $101
2018 $28
2017 $N/A
2016 $N/A
2015 $N/A
2014 $N/A
2013 $N/A
2012 $N/A
2011 $N/A
2010 $N/A
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $68.964B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $69.638B 26.78
Takeda Pharmaceutical (TAK) Japan $48.715B 9.94
Daiichi Sankyo, - (DSNKY) Japan $47.927B 24.56
BeOne Medicines - (ONC) Switzerland $34.411B 0.00
Sandoz Group AG (SDZNY) Switzerland $26.721B 0.00
Summit Therapeutics (SMMT) United States $19.321B 0.00
Merck (MKKGY) Germany $16.724B 10.87
Shionogi (SGIOY) Japan $14.853B 14.88
United Therapeutics (UTHR) United States $14.013B 12.13
Neurocrine Biosciences (NBIX) United States $13.417B 40.02
IPSEN (IPSEY) France $11.320B 0.00
Orion OYJ (ORINY) Finland $11.248B 27.11
Eisai (ESAIY) $9.064B 10.22
Madrigal Pharmaceuticals (MDGL) United States $9.039B 0.00
Corcept Therapeutics (CORT) United States $7.479B 62.81
Grifols, S.A (GRFS) Spain $6.931B 0.00
Stevanato Group S.p.A (STVN) Italy $6.920B 40.80
Ionis Pharmaceuticals (IONS) United States $6.891B 0.00
Ono Pharmaceutical (OPHLF) Japan $5.740B 19.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.405B 0.00
Soleno Therapeutics (SLNO) United States $3.710B 0.00
Procaps Group, S.A (PROCF) Luxembourg $3.225B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.993B 14.22
Crinetics Pharmaceuticals (CRNX) United States $2.769B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.753B 0.00
Hypermarcas (HYPMY) Brazil $2.692B 20.24
Catalyst Pharmaceuticals (CPRX) United States $2.516B 8.43
Centessa Pharmaceuticals (CNTA) United Kingdom $2.348B 0.00
Ocular Therapeutix (OCUL) United States $2.111B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.759B 0.00
Dyne Therapeutics (DYN) United States $1.738B 0.00
Guardian Pharmacy Services (GRDN) United States $1.665B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.590B 23.69
Ardelyx (ARDX) United States $1.472B 0.00
ARS Pharmaceuticals (SPRY) United States $1.470B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.439B 0.00
Harrow (HROW) United States $1.412B 0.00
Evotec AG (EVO) Germany $1.257B 0.00
Collegium Pharmaceutical (COLL) United States $1.245B 6.80
Xeris Biopharma Holdings (XERS) United States $1.226B 0.00
Enliven Therapeutics (ELVN) United States $1.175B 0.00
Cronos Group (CRON) Canada $0.981B 0.00
Akebia Therapeutics (AKBA) United States $0.846B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.753B 7.76
Amylyx Pharmaceuticals (AMLX) United States $0.752B 0.00
Theravance Biopharma (TBPH) United States $0.688B 56.92
ProKidney (PROK) United States $0.679B 0.00
KalVista Pharmaceuticals (KALV) United States $0.647B 0.00
Siga Technologies (SIGA) United States $0.627B 7.74
Elite Pharmaceuticals (ELTP) United States $0.594B 0.00
Tourmaline Bio (TRML) United States $0.592B 0.00
Relay Therapeutics (RLAY) United States $0.588B 0.00
Bioventus (BVS) United States $0.585B 14.16
Organogenesis (ORGO) United States $0.567B 0.00
USANA Health Sciences (USNA) United States $0.560B 11.47
Oruka Therapeutics (ORKA) United States $0.554B 0.00
Zevra Therapeutics (ZVRA) United States $0.534B 0.00
Nektar Therapeutics (NKTR) United States $0.533B 0.00
Xencor (XNCR) United States $0.531B 0.00
Savara (SVRA) United States $0.527B 0.00
Nanobiotix S.A (NBTX) France $0.467B 0.00
Esperion Therapeutics (ESPR) United States $0.429B 0.00
Aquestive Therapeutics (AQST) United States $0.390B 0.00
Aldeyra Therapeutics (ALDX) United States $0.352B 0.00
4D Molecular Therapeutics (FDMT) United States $0.320B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.314B 0.00
Altimmune (ALT) United States $0.312B 0.00
Larimar Therapeutics (LRMR) United States $0.305B 0.00
Nature's Sunshine Products (NATR) United States $0.293B 19.13
AleAnna (ANNA) United States $0.281B 0.00
Lexeo Therapeutics (LXEO) United States $0.258B 0.00
Galectin Therapeutics (GALT) United States $0.249B 0.00
OmniAb (OABI) United States $0.221B 0.00
Lyell Immunopharma (LYEL) United States $0.205B 0.00
Heron Therapeutics (HRTX) United States $0.202B 0.00
Korro Bio (KRRO) United States $0.193B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.191B 29.50
Aclaris Therapeutics (ACRS) United States $0.190B 0.00
MediWound (MDWD) Israel $0.188B 0.00
China SXT Pharmaceuticals (SXTC) China $0.182B 0.00
Innate Pharma SA (IPHYF) France $0.173B 0.00
Journey Medical (DERM) United States $0.165B 0.00
MEI Pharma (MEIP) United States $0.150B 0.00
Achieve Life Sciences (ACHV) Canada $0.148B 0.00
Profound Medical (PROF) Canada $0.138B 0.00
Avita Medical (RCEL) United States $0.126B 0.00
Inhibikase Therapeutics (IKT) United States $0.125B 0.00
Avalo Therapeutics (AVTX) United States $0.123B 0.00
Protara Therapeutics (TARA) United States $0.120B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.119B 0.00
Cassava Sciences (SAVA) United States $0.104B 0.00
Champions Oncology (CSBR) United States $0.102B 23.16
Cardiol Therapeutics (CRDL) Canada $0.098B 0.00
Surrozen (SRZN) United States $0.097B 0.00
ESSA Pharma (EPIX) Canada $0.091B 0.00
BioNxt Solutions (BNXTF) Canada $0.087B 0.00
Dominari Holdings (DOMH) United States $0.086B 0.00
Pyxis Oncology (PYXS) United States $0.082B 0.00
VAXART, INC (VXRT) United States $0.082B 0.00
Context Therapeutics (CNTX) United States $0.079B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
PMV Pharmaceuticals (PMVP) United States $0.078B 0.00
Unicycive Therapeutics (UNCY) United States $0.075B 0.00
Assertio Holdings (ASRT) United States $0.074B 0.00
Liminatus Pharma (LIMN) United States $0.072B 0.00
Vivani Medical (VANI) United States $0.072B 0.00
Nutriband (NTRB) United States $0.070B 0.00
Metagenomi (MGX) United States $0.069B 0.00
Gain Therapeutics (GANX) United States $0.065B 0.00
Wellgistics Health (WGRX) United States $0.064B 0.00
Prelude Therapeutics (PRLD) United States $0.062B 0.00
Inotiv (NOTV) United States $0.060B 0.00
DURECT (DRRX) United States $0.059B 0.00
PolyPid (PYPD) Israel $0.055B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.054B 0.00
Karyopharm Therapeutics (KPTI) United States $0.052B 0.00
Jupiter Neurosciences (JUNS) United States $0.052B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
NRx Pharmaceuticals (NRXP) United States $0.050B 0.00
Fractyl Health (GUTS) United States $0.050B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 29.45
Telomir Pharmaceuticals (TELO) United States $0.048B 0.00
Plus Therapeutics (PSTV) United States $0.048B 0.00
Century Therapeutics (IPSC) United States $0.047B 0.00
FibroGen (FGEN) United States $0.045B 0.00
Klotho Neurosciences (KLTO) United States $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Tempest Therapeutics (TPST) United States $0.042B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Mural Oncology (MURA) Ireland $0.036B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Vivos Therapeutics (VVOS) United States $0.035B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
Iterum Therapeutics (ITRM) Ireland $0.033B 0.00
CASI Pharmaceuticals (CASI) China $0.030B 0.00
Natural Alternatives (NAII) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Cosmos Health (COSM) United States $0.023B 0.00
Aptorum Group (APM) United Kingdom $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Mangoceuticals (MGRX) United States $0.017B 0.00
Scienture Holdings (SCNX) United States $0.016B 0.00
Lipocine (LPCN) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Ainos (AIMD) United States $0.016B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.016B 0.00
BioLineRx (BLRX) Israel $0.015B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Incannex Healthcare (IXHL) Australia $0.013B 0.00
TherapeuticsMD (TXMD) United States $0.013B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Ernexa Therapeutics (ERNA) United States $0.012B 0.00
BioVie (BIVI) United States $0.011B 0.00
Heatwurx (PCSA) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Talphera (TLPH) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.02
Carisma Therapeutics (CARM) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.008B 0.00
VYNE Therapeutics (VYNE) United States $0.008B 0.00
Indaptus Therapeutics (INDP) United States $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.005B 0.00
Aditxt (ADTX) United States $0.005B 0.00
CDT Equity (CDT) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.003B 0.00
SHINECO (SISI) China $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
SciSparc (SPRC) Israel $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
Indivior (INDV) United States $0.000B 13.51
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Minerva Neurosciences (NERV) United States $0.000B 1.63
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00